D
David W. Johnson
Researcher at University of Queensland
Publications - 2880
Citations - 157072
David W. Johnson is an academic researcher from University of Queensland. The author has contributed to research in topics: Peritoneal dialysis & Kidney disease. The author has an hindex of 160, co-authored 2714 publications receiving 140778 citations. Previous affiliations of David W. Johnson include Minnesota Department of Transportation & Open University.
Papers
More filters
Journal ArticleDOI
A randomized controlled trial of coiled versus straight swan-neck Tenckhoff catheters in peritoneal dialysis patients.
David W. Johnson,Jennifer Wong,Kathryn J. Wiggins,Robyn Kirwan,A. Griffin,John Preston,D. Wall,Scott B. Campbell,Nicole M. Isbel,David W. Mudge,Carmel M. Hawley,David Nicol +11 more
TL;DR: In this article, the effects of straight versus coiled peritoneal dialysis catheters on time to catheter malposition (primary outcome), catheterassociated infection, technique failure, and all-cause mortality were investigated.
Journal ArticleDOI
The emerging role of nuclear factor kappa B in renal cell carcinoma.
TL;DR: An overview of RCC, its molecular mechanisms, the role of NF-κB in carcinomas including R CC, and the rationale for NF-σB as a target molecule are provided.
Journal ArticleDOI
Constructive Conflict in the Schools
TL;DR: In this paper, the authors present three steps in establishing a cooperative context, primarily through the use of cooperative learning, to create intellectual conflicts through the creation of structured academic controversies, and establish a peer mediation program in which students try to negotiate integrative agreements to their conflicts of interests and, if negotiations fail, to seek the help of a peer mediator.
Journal ArticleDOI
Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials
Yeoungjee Cho,David W. Johnson,Sunil V. Badve,Jonathan C. Craig,Giovanni F.K. Strippoli,Kathryn J. Wiggins +5 more
TL;DR: Icodextrin prescription improved peritoneal ultrafiltration, mitigated uncontrolled fluid overload and was not associated with increased risk of adverse events.
Journal ArticleDOI
The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balanz trial
David W. Johnson,Fiona G. Brown,Margaret Clarke,Neil Boudville,Tony J Elias,Marjorie Foo,Bernard Jones,Hermant Kulkarni,Robyn G Langham,Robyn G Langham,Dwarakanathan Ranganathan,John Benedict William Schollum,Michael Suranyi,Seng Tan,David Voss +14 more
TL;DR: Biocompatible PD fluid use was associated with a broad reduction in gram-positive, gram- negative, and culture-negative peritonitis that reached statistical significance for non-pseudomonal gram-negative organisms.